Genetic Fate Mapping Reveals Endothelial Cells During Venous Thrombus Resolution – RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Magdalena L. Bochenek et al, adding:
“New RPTH research used a genetic fate mapping approach to visualize tamoxifen–inducible endothelial receptor tyrosine kinase (TIE2) reporter ECs during venous thrombus resolution and human pulmonary thrombi of different organizational stages to validate findings.
This time course analysis may aid the refinement of revascularization strategies in humans.
Tune in as co-authors Katrin Schäfer and Magdalena Bochenek discusses this new research with RPTH social media associate editor Nicolas Gendron.”
Title: Visualization of new vessel formation during venous thrombus organization using genetic fate mapping
Authors: Magdalena L. Bochenek, Julie D. Noorali, Aden Aderajew, Kateryna Moiko, Stefanie Zimmer, Konstantinos Zifkos, Mathias Wagner, Philipp Lurz, Lukas Hobohm, Katrin Schäfer
More posts featuring RPTH Journal on Hemostasis Today.
-
Sep 19, 2026, 01:39Mostafa Hammam: Three Different Platelet Defects – One Common Symptom
-
Sep 19, 2026, 01:38Jeff Sternlicht: A Heart Attack Should Not Be the Starting Line
-
Sep 19, 2026, 01:28Luis Oliverio Ambriz Garcia: Key Points From the ASH 2026 Guidelines on Iron Deficiency
-
Sep 19, 2026, 01:27Farjah Algahtani: A New Era in the Treatment of Transfusion-Dependent Thalassaemia
-
Sep 19, 2026, 01:24Aravind Palraj: 2025 EULAR Behçet’s Syndrome Update – 5 Practical Take-Home Points
-
Sep 19, 2026, 01:23Chokri Ben Lamine: Cemdisiran in PNH – Why Combine Complement Therapies?
-
Sep 19, 2026, 01:19Stefano Garzon: Comparing DOACs SAPT and DAPT After LAAO
-
Sep 19, 2026, 01:18Elad Asher: What Should a Patient Take after Left Atrial Appendage Occlusion?
-
Sep 19, 2026, 00:48Mahmoud Mehawed: Heparin vs Warfarin vs DOACs Understanding the Key Differences